Antinociceptive and anti-inflammatory effect of Poincianella pyramidalis (Tul.) L.P. Queiroz.

dc.contributor.authorMoraes, Sabrina Zelice da Cruz de
dc.contributor.authorShan, Andrea Yu Kwan Villar
dc.contributor.authorMelo, Marlange Almeida Oliveira
dc.contributor.authorSilva, Juliane Pereira da
dc.contributor.authorPassos, Fabiolla Rocha Santos
dc.contributor.authorGraça, Ariel de Souza
dc.contributor.authorAraújo, Brancilene Santos de
dc.contributor.authorQuintans, Jullyana de Souza Siqueira
dc.contributor.authorQuintans Júnior, Lucindo José
dc.contributor.authorBarreto, Emiliano de Oliveira
dc.contributor.authorBrandão, Geraldo Célio
dc.contributor.authorEstevam, Charles dos Santos
dc.date.accessioned2021-12-06T20:09:51Z
dc.date.available2021-12-06T20:09:51Z
dc.date.issued2020pt_BR
dc.description.abstractEthnopharmacology relevance: Poncianella pyramidalis (Leguminosae) is a Caatinga plant used in folk medicine because of its pharmacological properties, which include anti-inflammatory action. However, chemical compounds re sponsible for this effect have not yet been identified. Aim of the study: This study aimed to evaluate the antioxidant, antinociceptive and anti-inflammatory effects of the ethyl acetate fraction from the inner bark of P. pyramidalis. Material and methods: Total phenol content (TP) was estimated using the Folin-Ciocalteu reagent, while in vitro antioxidant activity was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging assay. Chemical identification was done using LC-PDA/MS and LC-ESI/MS/MS. In vivo antinociceptive and anti-in flammatory properties were investigated using formalin, mechanical hypernociception and carrageenan-induced pleurisy assays in mice. Results: TP was 525.08 ± 17.49 μg mg−1 gallic acid equivalent. The ethyl acetate fraction (EAF) inhibited 87.76% of the DPPH radical with an EC50 of 22.94 μg mL−1 and Antioxidant Activity Index of 1.74. LC-PDA/MS and LC-ESI/MS/MS identified 15 compounds that are mostly derived from gallic and ellagic acids. Regarding in vivo antinociceptive and anti-inflammatory activity, EAF (100 mg kg-1) significantly reduced the nociceptive response in the second phase of the formalin assay by 50% (p < 0.01) compared with the control group. In the hypernociception test, a significant (p < 0.001) anti-hyperalgesic effect of EAF (100 mg kg-1) was observed up to the third hour of evaluation (p < 0.001). In the carrageenan assay, EAF (100 mg kg-1) was shown to inhibit protein extravasation, increase total leukocytes and neutrophils, and inhibit mononuclear cells. Conclusion: These results demonstrate EAF from the inner bark of P. pyramidalis has strong in vitro antioxidant effect as well as in vivo antinociceptive and anti-inflammatory activities, which may be attributed to the bark being rich in phenolic compounds derived from gallic acid.pt_BR
dc.identifier.citationMORAES, S. Z. da C. de et al. Antinociceptive and anti-inflammatory effect of Poincianella pyramidalis (Tul.) L.P. Queiroz. Journal of Ethnopharmacology, p. 112563, 2020. Disponível em: <https://www.sciencedirect.com/science/article/abs/pii/S0378874119319257?via%3Dihub>. Acesso em: 10 jun. 2021.pt_BR
dc.identifier.doihttps://doi.org/10.1016/j.jep.2020.112563pt_BR
dc.identifier.issn0378-8741
dc.identifier.urihttp://www.repositorio.ufop.br/jspui/handle/123456789/14096
dc.identifier.uri2https://www.sciencedirect.com/science/article/abs/pii/S0378874119319257?via%3Dihubpt_BR
dc.language.isoen_USpt_BR
dc.rightsrestritopt_BR
dc.subjectPhenolicpt_BR
dc.subjectCarrageenanpt_BR
dc.subjectHyperalgesicpt_BR
dc.subjectHypernociceptionpt_BR
dc.titleAntinociceptive and anti-inflammatory effect of Poincianella pyramidalis (Tul.) L.P. Queiroz.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
ARTIGO_AntinociceptiveAntiinflammatoryEffect.pdf
Tamanho:
1.52 MB
Formato:
Adobe Portable Document Format
Descrição:
Licença do Pacote
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: